Platform
Features
0 followers
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.
Industries
Headquarters
Employees
Links
Jaume Pons
11 members
9 members
7 members
Emergent BioSolutions
4 followers
Owkin
Synthekine
3 followers
GOURMEY
19 followers
Forge Biologics
2 followers
Obsidian Therapeutics
1 follower
MassBio
PMV Pharmaceuticals
Generate Biomedicines
Spark Capital
20 followers
UNC Charlotte
6 followers
Discover companies